Growth Metrics

Nu-Med Plus (NUMD) Equity Ratio (2011 - 2025)

Nu-Med Plus recorded quarterly Equity Ratio of 34.29 in Q4 2025, up 33.08% quarter-over-quarter from 51.24 in Q3 2025, and down 49.43% year-over-year from 67.81 in Q4 2024.

Nu-Med Plus' Equity Ratio history runs 15 years deep, the most recent figure standing at 34.29 for Q4 2025.

  • In Q4 2025, Equity Ratio fell 49.43% year-over-year to 34.29; the TTM figure through Dec 2025 stood at 34.29 (down 49.43% YoY), while the FY2025 annual figure was 34.29, down 49.43% from the prior year.
  • Equity Ratio came in at 34.29 for Q4 2025 at Nu-Med Plus, up from 51.24 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.67 in Q1 2021 to a low of 85.27 in Q3 2022.
  • A 5-year average of 21.03 and a median of 17.77 in 2024 frame the typical range for Equity Ratio.
  • Across the five-year window, Equity Ratio surged 108.61% in 2021 and plunged 157942.44% in 2022, its largest moves.
  • Nu-Med Plus' Equity Ratio stood at 5.97 in 2021, then soared by 86.73% to 0.79 in 2022, then tumbled by 1276.46% to 10.91 in 2023, then sank by 110.42% to 22.95 in 2024, then tumbled by 49.43% to 34.29 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods registered 34.29, 51.24, and 30.22 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 Nu-Med Plus - - - -34.29

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -34.29
Sep 30, 2025 -51.24
Jun 30, 2025 -30.22
Mar 31, 2025 -45.43
Dec 31, 2024 -22.95
Sep 30, 2024 -29.90
Jun 30, 2024 -16.83
Mar 31, 2024 -18.70
Dec 31, 2023 -10.91
Sep 30, 2023 -9.60
Jun 30, 2023 -3.16
Mar 31, 2023 -1.54
Dec 31, 2022 -0.79
Sep 30, 2022 -85.27
Jun 30, 2022 -29.28
Mar 31, 2022 -23.85
Dec 31, 2021 -5.97
Sep 30, 2021 -1.37
Jun 30, 2021 -0.02
Mar 31, 2021 0.67
Dec 31, 2020 0.84
Sep 30, 2020 0.34
Jun 30, 2020 0.48
Mar 31, 2020 -7.78
Dec 31, 2019 -8.09
Sep 30, 2019 -3.63
Jun 30, 2019 -5.82
Mar 31, 2019 -1.45
Dec 31, 2018 0.11
Sep 30, 2018 0.35
Jun 30, 2018 -0.07
Mar 31, 2018 -0.06
Dec 31, 2017 0.17
Sep 30, 2017 0.10
Jun 30, 2017 -0.31
Mar 31, 2017 -0.10
Dec 31, 2016 -124.93
Sep 30, 2016 -0.54
Jun 30, 2016 0.61
Mar 31, 2016 -2.00
Dec 31, 2015 -200.45
Sep 30, 2015 -3.44
Jun 30, 2015 -2.04
Mar 31, 2015 -1.75
Dec 31, 2014 -33.38
Sep 30, 2014 -0.25
Jun 30, 2014 0.52
Mar 31, 2014 0.49
Dec 31, 2013 -1.29
Sep 30, 2013 -2.19
Jun 30, 2013 -2.36
Mar 31, 2013 -1.84
Dec 31, 2012 -0.42
Dec 31, 2011 -0.21